We used an immunohistochemical method to examine the localization of monoamine oxidase type B (MAOB) in rat liver. At the light microscopic level, MAOB was highly expressed in rat liver. It was intense around portal area, and weak around central area. All the hepatocytes examined had MAOB immunoreactivity. For the first time, using a doublelabeling immunofluorescence histochemical method for laser microscopy, we report that no MAOB is found in endothelial cells, hepatic stellate cells, or Kupffer's cells. When examined under transmission electron microscopy, MAOB was localized to the mitochondrial outer membrane of hepatocytes. No apparent localization of MAOB was found in the rough endoplasmic reticulum, the crystal membrane of mitochondria, the nuclear envelope, or the plasma membrane.
Medical University. They were housed in temperature-, humidity-, and light-controlled rooms (23±1°C, 50±5%, and light on from 8:00 a.m. to 8:00 p.m.), and had free access to standard food and tap water.
Primary antibodies
Sheep antibodies against rat albumin (Bethyl Laboratories, Montgomery, USA), mouse antibodies against human CD34, smooth muscle-specific α-actin (SMSA), and CD68 (DAKO, Carpinteria, CA, USA) were used. These antibodies have been previously characterized (Cizkova et al., 2005; Chedid et al., 2004) .
MAOB purified from bovine liver mitochondria was used to generate a rabbit anti-MAOB antiserum (Sagara and Ito, 1982) . The specificity of this antiserum is described in the discussion.
Preabsorption test
Based on Ma and Ito (2002) , cDNA of rat liver MAOB was prepared in a hexa-histidine tagged form, expressed in Escherichia coli, and purified using a HisTrap chelating column. The recombinant protein was used for a preabsorption test as follows.Thirty milligrams of rat MAOB protein was added to 1 mL of diluted anti-MAOB antiserum (1:50,000), and the mixture (0.5 mM MAOB) was incubated for 24 hours at 4°C. Using this preabsorbed antiserum, sections of the liver were processed for immunofluorescence histochemistry as described below.
Double-labeling immunofluorescence histochemistry
Three rats were anesthetized with sodium pentobarbital (60 mg/kg body weight, i.p.) and perfused through the ascending aorta with 150 mL of 0.01 M phosphate-buffered saline (PBS; pH 7.4), followed by 300 mL of a fixative solution containing 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4).The livers were dissected and placed in the same fixative solution for 24 hours, and then immersed in PB containing 15% sucrose. 10 µm thick sections were cut using a cryostat (Cryocut 1800, Reichert-Jung, Heiderberg, Germany), and collected in PBS.
Double-labeling of MAOB and each of liver cell markers was performed as follows. Sections were incubated in the following solutions: (1) 0.3% Triton X-100 in PBS for 1 hour; (2) 1% bovine serum albumin (BSA) in PBS for 1 hour; (3) a mixture of primary antisera: rabbit antiserum against MAOB (dilution, 1:5,000) combined with one of the four antisera: sheep anti-albumin antiserum (dilution, 1:2,000), mouse anti-CD34 antiserum (dilution, 1:200), mouse anti-SMSA antiserum (dilution, 1:200), and mouse anti-CD68 antiserum (dilution, 1:200) for 48 hours; and (4) a mixture of secondary antisera: Alexa Fluor 488-conjugated goat anti-rabbit immunoglobulin G (IgG) (dilution, 1:200; Molecular Probes, Eugene, Oregon, USA,) combined with one of the two antisera: Cy3-conjugated donkey anti-sheep IgG (dilution, 1:200; Chemicon, Temecula, CA, USA,), and Cy3-conjugated donkey anti-mouse IgG (dilution, 1:200; Chemicon) for 2 hours. Finally, MAOB was labeled with Alexa Fluor 488 (green), Albumin, CD34, SMSA, and CD68 were labeled with Cy3 (red). The stained sections were observed under a confocal laser scanning microscope (LSM510, Zeiss, Jena, Germany).
Electron microscopic immunohistochemistry
Three rats were anesthetized with sodium pentobarbital (60 mg/kg body weight, i.p.) and perfused through the ascending aorta with 150 ml of 0.01 M PBS, followed by 300 ml of a fixative solution containing 4% paraformaldehyde, 0.3% glutaraldehyde, and 0.2% picric acid in 0.1 M PB. The livers were dissected and placed in another fixative solution containing 4% paraformaldehyde and 0.2% picric acid in PB for 24 hours. 30 µm thick sections were cut using a vibratome (DTK-3000, Dosaka, Kyoto, Japan), and collected in PBS.
For MAOB staining, an immunoperoxidase technique using avidin-biotin-peroxidase complex (Hsu et al., 1981) was performed. Sections were incubated in the following solutions: (1) 0.001% trypsin (type III, Sigma, St. Louis, MO, USA) in PBS for 5 minutes; (2) 5% normal goat serum in PBS for 1 hour; (3) rabbit anti-MAOB antiserum (dilution, 1:5,000) for 48 hours; (4) biotinlyted goat anti-rabbit IgG (dilution, 1:1,000; Vector, Burlingame, USA) for 2 hours; (5) avidin-biotinperoxidase complex (dilution, 1:1,000; Vector) for 2 hours; and (6) 0.025% 3,3'-diaminobenzidine (Dojindo, Kumamoto, Japan), 0.6% nickel ammonium sulfate (Nacalai Tesque, Kyoto, Japan), and 0.0075% hydrogen peroxide (H2O2) in 0.05 M trizma hydrochloride (Tris-HCl) buffer (pH 7.6) for 5 minutes. The stained sections were fixed with 1% osmium tetroxide (Nacalai Tesque, Kyoto, Japan) for 1 hour, dehydrated and flat-embedded in epoxy resin (Luveak-812, Nacalai Tesque, Kyoto, Japan). Small areas were trimmed from the embedded section and cut on an ultramicrotome (Ultracut UCT, Leica, Heiderberg, Germany). Ultrathin sections were collected on grids (200, Cu, VECO, Eerbeek, Holland), stained with 2% uranyl acetate (Merck, Darmstadt, Germany) for 20 minutes and lead stain solution (Sigma-Aldrich Japan, Tokyo, Japan) for 5 minutes, and examined with a transmission electron microscope (H-7100TE, Hitachi, Tokyo, Japan).
Results

Preabsorption test
Preabsorption of the anti-MAOB antiserum with rat recombinant MAOB protein (0.5 mM) eliminated the immunostaining ( Figure 1B ). Figure 1A shows the localization of MAOB in rat liver. In all the samples examined, MAOB was highly expressed in the rat liver. It was intense around portal area, and weak around central area. Figure 2 shows the cellular localization of MAOB in rat liver. All of hepatocytes that were labeled for albumin were also stained for MAOB ( Figure 3 shows the subcellular localization of MAOB in rat liver. MAOB immunoreactivity was found on the mitochondrial outer membrane of hepatocytes. No apparent localization of MAOB was found in the rough endoplasmic reticulum, the crystal membrane of mitochondria, the nuclear envelope, or the plasma membrane.
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Discussion
In this report, using an immunohistochemical method, we presented results which localized MAOB in rat liver at the light and electron microscopic level. By light microscopy, we found that MAOB was highly expressed in rat liver. These are in general agreement with the findings of other researchers (Schnaitman et al., 1967; Lewinsohn et al., 1978; Ryder et al., 1979; Lenzen et al., 1983; Egashira and Waddell, 1984; Uchida and Koelle, 1984; Thorpe et al., 1987; Saura et al., 1992; Rodriguez et al., 2001; Ramonet et al., 2003; Sivasubramaniam et al., 2003) , which all show that both MAOA and MAOB are expressed in rat liver. But most of these studies use enzyme histochemistry, quantitative enzyme radioautography, spectrophotometric assay, and radiochemical assay. All of the above methods are neither sensitive nor specific, because no compounds show absolute isozyme specificity. All compounds described will interact
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Original Paper with both forms of MAO under favorable conditions (Berry et al., 1994) , such as 10 -3 M pargyline and 10 -4 M deprenyl, which inhibit both MAOA and MAOB (Ryder et al., 1979; Lewinsohn et al., 1980) . 5-hydroxytryptamine (5-HT), long considered to be a substrate only for MAOA, is mainly (70%) deaminated by MAOB, but with a higher Km (Stenstrom and Lundquist, 1990 ). In addition, most of them use tryptamine or tyramine (TYR) as substrates, which are substrates of both MAOA and MAOB. They can not distinguish between MAOA and MAOB. In the present study, we localized MAOB in the rat liver using antiserum against MAOB purified from the bovine liver mitochondria. Specific cross-reactivity of the anti-MAOB antiserum with rat MAOB was demonstrated as follows: (1) Solubilized mitochondria of the rat liver were subjected to immunoprecipitation with the anti-MAOB antiserum, and then the precipitate was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, showing a single band corresponding to a molecular mass that was calculated from cDNA of rat liver MAOB (Ito et al., 1988; Sagara and Ito, 1982) . (2) Immunohistochemical analysis showed that the anti-MAOB antiserum did cross react with MAOB but not MAOA in the rat brain . Furthermore, we showed in the present study that preabsorption of the anti-MAOB antiserum with rat recombinant MAOB protein eliminated the immunohistochemical staining. Altogether, these findings indicate that the immunohistochemical staining with the anti-MAOB antiserum show the localization of MAOB in the rat liver.
Our results showed that all the hepatocytes examined had MAOB immunoreactivity. It was intense around portal area, and weak around central area. The reason for uneven distribution may reflect a difference in supplying blood and oxygen. The hepatocytes around portal area, which are first exposed to the blood entering the lobule, oxidative respiration via the Krebs cycle may operate at a high level. The enzyme activity is higher. While the cells around the central area, which carry the blood leaving the lobule, the enzyme activity is lower.
In this study, we stained the hepatocytes, endothelial cells, hepatic stellate cells, and Kupffer's cells with antibodies against albumin, CD34, SMSA, and CD68. Because previous studies have shown that these four antibodies are the best maker for each cell type (Cizkova et al., 2005; Chedid et al., 2004) . For the first time, using a double-labeling immunofluorescence histochemical method for laser microscopy, we reported that in rat liver, no MAOB immunoreactivity was found in endothelial cells, hepatic stellate cells, or in Kupffer's cells. Though there were reports that MAOB is localized on capillary endothelial cells of rat tongue (Xu et al., 2002) , hepatic stellate cells of rat liver (Muller and Lage., 1977) , and Kupffer's cells of human peripheral blood (Seiler et al., 1995) . In fact, at electron microscopic level, we also found no MAOB was expressed in endothelial cells, hepatic stellate cells, or in Kupffer's cells (data not show). These maybe due to a difference in experimental methods and tissues. The exact reason remains to be explored.
When examined under transmission electron microscopy, MAOB was localized to the mitochondrial outer membrane of hepatocytes.These results are in general agreement with those of Shannon et al. (1974) and Muller and Lage (1977) . By
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Original Paper enzyme histochemistry, Shannon et al. (1974) found MAO reaction products in mitochondrial outer compartment, the rough endoplasmic reticulum, and the nuclear membrane of unfixed guinea pig liver, Muller and Lage (1977) described that MAO was localized to the mitochondrial outer membrane, the rough endoplasmic reticulum, the crystal membrane of mitochondria, the nuclear envelope, and the plasma membrane of rat hepatocytes and hepatic stellate cells. Whereas, we did not find any apparent localization of MAOB in the rough endoplasmic reticulum, the crystal membrane of mitochondria, the nuclear envelope, nor the plasma membrane. The reason maybe due to a difference in experimental methods. They use an enzyme histochemical method, it is neither sensitive nor specific. We use immunohistochemical method, it is sensitive and specific.
MAO is enzyme that degrades a wide range of monoamines. The primary roles of MAO lie in the metabolism of exogenous amines and the control of neurotransmitter levels and intracellular amine stores (Billett, 2004) . It is found in two functionally distinct forms, MAOA and MAOB. They differ in substrate preference, inhibitor specificity, tissue and cell distribution, immunological property, and apparent molecular weight (Berry et al., 1994) . Under normal physioloical conditions, MAOA preferentially oxidases 5-HT and norepinephrine (NE), whereas MAOB oxidases phenylethylamine (PEA) preferentially, with dopamine (DA) and TYR being substrates for both isoenzymes. MAOA is inhibited by low concentrations of clorgyine, and MAOB by low concentration of deprenyl (Billett, 2004) .
MAOB is a typical intrinsic protein of the outer mitochondrial membrane. It is synthesized in cytoplasmic polysomes (Sagara and Ito, 1982) . It has an uncleavable targeting signal and is inserted into the outer membrane without proteolytic maturation. The targeting signal is present within its carboxy-terminal 29 amino acid residues (Mitoma and Ito, 1992) . It inserts into the membrane by ubiquitin (a 76-amino acid polypeptide), with energy provided by ATP (Zhaung and McCauley, 1989) .
Biochemical and histochemical results indicate large differences of MAO characteristics between animal species as well as in varying tissues. It is considered that the specific localization of the two forms of MAO within different body tissues is of biological and clinical significance (Stenstrom and Lundquist, 1990; Billett, 2004) . The expression of MAO in liver suggests that this enzyme may play an important role in liver. In the disease of hepatic encephalopathy (HE), the neueotransmitters, such as DA, 5-HT, NE, and γ-aminobutyric acid (GABA), the neurotransmitters metabolites, such as asparagines, glutamine, homovanillic acid, normetanephrine, 5-hydroxyindolacetic acid (5-HIAA), and indole-3-acetic acid (IAA) are increased in cerebrospinal fluid (Zieve, 1987) . MAO is the main degradation enzymes of monoamine hormones and amine neurotransmitters, such as epinephrine (E), NE, 5-HT, and DA (Billett, 2004) . From these, we speculate that MAO may play an important role in liver function and in liver diseases.This is supported by the work of Rao et al. (1993) . Using radioenzymatic assay, Rao et al. (1993) measured activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients who died in HE. They found the activities of both MAOA and MAOB were significantly increased in frontal cortex and caudate nucleus, and concluded that increased monoamine metabolism and subsequent modifications of monoaminergic synaptic function could contribute to the pathogenesis of HE. MAOB in liver has the ability to deaminate certain amines. In the process of deamination, ammonia are generated (Berry et al. 1994 ). This substance is normally removed by the hepatobiliary route and that in liver failure accumulate in the brain. This alters the expression of key astrocytic proteins in astrocytes of the brain. Recent molecular biological studies show an increased expression of several genes coding for neurotransmitter-related proteins in chronic liver failure. Such genes include those for MAOB, glutamine synthetase, and the so-called peripheraltype benzodiazepine receptors. In addition, expression of some neuronal proteins such as MAOA and neuronal nitric oxide synthase are modified. Activation of these systems may lead to alterations of monoamine and amino acid neurotransmitter function and changes in cerebral blood flow in chronic liver failure. Available evidence suggests that neurotransmission changes rather than brain energy failure are the primary cause of HE (Hazell and Butterworth, 1999) . Up to now, the exact role of MAO in liver and the mechanism of the change of MAO activity in brain of liver diseases are not completely understood. Further research is required regarding this question.
